Literature DB >> 3680689

MR imaging in a case of Hallervorden-Spatz disease.

G Tanfani1, M Mascalchi, G C Dal Pozzo, N Taverni, A Saia, C Trevisan.   

Abstract

Magnetic resonance using a 0.5 T system and a T2-weighted spin-echo pulse sequence revealed symmetric areas of marked hypointensity of the globi pallidi in a case with a family history of and presenting with clinical features consistent with Hallervorden-Spatz disease. No such findings were seen in any of 16 normal volunteers of similar age. Magnetic resonance may be useful for diagnosing Hallervorden-Spatz disease.

Entities:  

Mesh：

Year:  1987        PMID： 3680689     DOI： 10.1097/00004728-198711000-00027

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN： 0363-8715            Impact factor:   1.826


  9 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Clinicopathological study of familial late infantile Hallervorden-Spatz disease: a particular form of neuroacanthocytosis.

Authors:  A Malandrini; G M Fabrizi; P Bartalucci; C Salvadori; G Berti; C Sabò; G C Guazzi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

Review 3.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

4.  Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.

Authors:  S J Hayflick; M Hartman; J Coryell; J Gitschier; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

5.  Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease.

Authors:  M Feliciani; P Curatolo
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

Review 6.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

7.  Hallervorden Spatz disease.

Authors:  Chandrika Rao; Venkata Murthy; Radhakrishna Hegde
Journal:  Indian J Pediatr       Date:  2003-06       Impact factor: 1.967

8.  Hallervorden-Spatz Syndrome with Seizures.

Authors:  Sunil Gothwal; Swati Nayan
Journal:  Basic Clin Neurosci       Date:  2016-04

9.  Pantothenate kinase-associated neurodegeneration (PKAN) in a child with Down syndrome. A case report and follow-up with MRI.

Authors:  A Hakim; C Rozeik; M Fedorcak
Journal:  BJR Case Rep       Date:  2015-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.